Medpace News and Activities
Presence
Medpace is a full-service clinical contract research organization (CRO) that provides a broad range of services to the pharmaceutical, biotechnology, and medical device industries. They specialize in clinical trial management and support, including regulatory submissions and biostatistical analysis. Their target customers are primarily companies in the life sciences sector seeking to bring new drugs and devices to market.
Medpace products and services overview:
- Clinical Operations
- Regulatory Affairs
- Medical Affairs
- Data Management
- Biostatistics
2024 Revenue: $1.2 billion
Employees: 3,500
Medpace is one of the...
Medpace is a company listed under the stock ticker MEDP (US).
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Medpace
Create your alert
to follow the executive moves at Medpace.
Pharmaceuticals
Medpace has 1,838 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- ESSA Pharma and Xoma have announced they will merge (posted on July 14 2025)..
- Pathos becomes a unicorn with its fundraising of $365 Million. (posted on July 4 2025).
- Vor Biopharma and Incyte have announced they will merge (posted on June 30 2025)..
Popular contacts in Pharmaceuticals
News
Press releases by Medpace
- DalCor Achieves 50 percent Enrollment Milestone for Phase 3 Cardiovascular Trial
- Actinium Pharmaceuticals Selects Medpace Inc. as Clinical Research Organization for Pivotal Phase 3 Iomab-B Trial :: Actinium Pharmaceuticals, Inc. (ATNM)
Social media about Medpace
- Medpace on Wikipedia, Google News & Yahoo Finance
- Medpace on LinkedIn, Twitter & YouTube
